Elix CEO Shinya Yuki and Application Scientist Takahiro Inoue will participate in the session
“Current Status of Accelerated Drug Discovery – How In Silico Is Enabling New Approaches in Drug Discovery and Clinical Development” at Healthtech Summit 2025 on Monday, December 8, 2025.

CEO Shinya will join the panel discussion to share insights on the latest trends and future outlook of drug discovery and clinical development using AI and In Silico technologies.
Application Scientist Takahiro will demonstrate the actual application of these technologies during the session.

◾️Session Details
Date & Time: Monday, December 8, 2025 | 11:10 AM – 12:10 PM
Venue: Muromachi Mitsui Hall & Conference

◾️Event Details & Official Website
Healthtech Summit Official Site (Japanese only)